Bernhard Scheiner
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 215 publications
Corrigendum to: 'Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk' [JHEP Reports (2026) 19;8(9):101932].
Journal: JHEP reports : innovation in hepatology
Published: September 03, 2026
Noninvasive test patterns across vascular and parenchymal liver diseases.
Journal: Wiener klinische Wochenschrift
Published: May 15, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 10, 2026
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.
Journal: Annals of hepatology
Published: February 26, 2026
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.
Journal: Annals of hepatology
Published: February 26, 2026
Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 13, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 13, 2025
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 28, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 10, 2025
Stage-Specific Drivers of Clinical Progression in Advanced Chronic Liver Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 07, 2025
Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCC.
Journal: JHEP reports : innovation in hepatology
Published: September 24, 2025
Last Updated: 09/26/2026